2024. Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s480. DOI:https://doi.org/10.25251/skin.8.supp.480.